In combating COVID-19, science is how we get back to normal

Lori Reilly   |     June 24, 2020   |   SHARE THIS

America’s biopharmaceutical companies are working around the clock to combat a common enemy: COVID-19. As the fight to research and develop innovative treatments and vaccines advances, I’m pleased to share our new TV ad, highlighting how we are working together to help end the global pandemic. Beginning today, the ad will appear on national cable and broadcast channels as well as online.



In the ad, three scientists detail how the biopharmaceutical industry is making progress to develop treatment and vaccine candidates against COVID-19 by collaborating in ways we’ve never done before.


We’ve made incredible progress in a matter of weeks, as we now have several vaccine candidates along with potential therapeutics that have shown positive results. Today, there are over 1,200 clinical trials for treatments and vaccines for COVID-19. Already, there are 13 vaccines in active clinical trials with over 120 in preclinical testing; these trials are occurring across 45 states and the District of Columbia.


In creating this ad, we’re proud to highlight several inspiring scientists that represent the more than 140,000 researchers across the country who are looking for vaccines, treatments and cures for coronavirus and other diseases. The three scientists in this ad also reflect the strong role women play in the life sciences industry, where women account for nearly half of the workforce up from just a third in 1990.

To learn more about biopharmaceutical efforts to combat coronavirus, visit PhRMA.org/Coronavirus.

Lori Reilly

Lori Reilly Lori M. Reilly is Chief Operating Officer, providing executive level management, leadership and strategic direction at the Pharmaceutical Research and Manufacturers of America (PhRMA). In this role, Ms. Reilly oversees PhRMA’s Advocacy activities, including its federal, state, and international government affairs and alliance development work. Ms. Reilly provides strategic leadership and works across PhRMA to develop and advocate for practical policy solutions that will lower costs for patients. Ms. Reilly, named by the Hill as a top lobbyist in 2018, has a long record of working with members of Congress on a bipartisan basis and collaborating with stakeholders across the health care industry. Ms. Reilly is a frequent presenter on industry-related issues, including testifying before Congress on multiple occasions. Ms. Reilly has nearly two decades of experience at PhRMA; prior to her current role, Ms. Reilly was the Executive Vice President of Policy, Research, and Membership at PhRMA, leading the development and implementation of legislative, regulatory, and political strategies to advance policies that encourage patient access and medical innovation. She has also served as counsel at the U.S. House of Representatives Committee on Commerce and was Counsel to a member of the House Ways and Means Committee. Ms. Reilly received a B.A. in Political Science from the University of Nebraska-Lincoln where she graduated with Honors, and a J.D. from the University of Nebraska College of Law. She is currently resides in Alexandria, Virginia with her husband and their four children.

Topics: Research and Development, PhRMA Member Company, Coronavirus

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates